Instrument Inactif

Autres langues PHARMING GROUP Euronext Amsterdam

Actions

NL0000377018

Produits pharmaceutiques

Cours en clôture Euronext Amsterdam
- ^EUR	-

13/08	Pharming lance le Joenja au Japon pour les patients adultes et pédiatriques atteints d'APDS	MT
13/08	Pharming Group lance Joenja au Japon, un traitement contre une immunodéficience primaire rare	MT

Autres langues

13/08	Pharming Launches Joenja in Japan for Adult, Pediatric APDS Patients
13/08	Pharming Group Launches Rare Primary Immunodeficiency Therapy Joenja in Japan
13/08	Pharming lanceert Joenja voor APDS-patiënten in Japan
13/08	Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
13/08	Pharming Group Announces Commercial Launch of Joenja in Japan for Adult and Pediatric Patients with Apds Aged 4 and Older
04/08	Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
02/08	Drukke cijferweek op Damrak kent winnaars en verliezers
30/07	Pharming Group's Q2 Earnings, Revenue Fall; 2026 Revenue Outlook Updated
30/07	Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2026
30/07	Pharming stelt jaaroutlook naar beneden bij
30/07	Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
30/07	Pharming Group N.V. Revises Earnings Guidance for the Year 2026
16/07	Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
14/07	Beleggersvertrouwen naar hoogste niveau in maanden
08/07	Pharming N : DWS Investment GmbH - Pharming Group N.V. - Leiden
08/07	Pharming N : DWS Investment GmbH - Pharming Group N.V. - Leiden
03/07	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
03/07	Pharming N : DWS Investment GmbH - Pharming Group N.V. - Leiden
03/07	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
03/07	Pharming N : DWS Investment GmbH - Pharming Group N.V. - Leiden
07/06	Databedrijven blinken uit te midden van chipmalaise
05/06	Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja to treat children aged 4 to 11 years with APDS
04/06	Pharming Group N.V. Announces U.S. FDA Acceptance of sNDA Resubmission for Joenja to Treat Children Aged 4 to 11 Years with APDS
04/06	Pharming Group Says Marketing Application for Immunodeficiency Disorder Drug Accepted by FDA
04/06	US FDA Accepts Pharming Group's Resubmitted Application for Immunodeficiency Treatment